CLYBL, or Citramalyl-CoA lyase, is a mitochondrial enzyme encoded by the gene "CLYBL". This protein plays a critical role in the metabolism of vitamin B12 and the tricarboxylic acid (TCA) cycle, which is a central pathway in cellular energy production. CLYBL catalyzes the reversible cleavage of citramalyl-CoA to acetyl-CoA and pyruvate, thereby linking the leucine degradation pathway with the TCA cycle.The TCA cycle is fundamental to aerobic respiration, as it generates high-energy electron carriers that feed into the oxidative phosphorylation pathway, leading to ATP production. By contributing to the pool of acetyl-CoA, a key TCA cycle intermediate, CLYBL facilitates the efficient flow of carbon within this vital metabolic pathway. The enzyme's activity is, therefore, essential for the maintenance of energy homeostasis in cells, particularly in tissues with high metabolic demands such as muscle and brain.
Beyond its metabolic role, CLYBL has been associated with genetic variations that impact vitamin B12 levels in humans. The gene contains a polymorphism that can lead to reduced enzyme function, potentially affecting vitamin B12 metabolism and contributing to variations in B12 levels among individuals. Since vitamin B12 is crucial for DNA synthesis, red blood cell formation, and neurological function, CLYBL's involvement in its metabolism has significant health implications.Given the enzyme's dual role in both the TCA cycle and vitamin B12 metabolism, CLYBL may serve as a molecular link between cellular energy production and essential nutrient processing. Understanding the regulation and interaction of CLYBL with other metabolic pathways remains an area of active research, with the potential to reveal novel insights into metabolic disorders and nutritional deficiencies.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
A diabetes medication that affects mitochondrial metabolism, could indirectly influence CLYBL activity. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activates AMPK, impacting energy metabolism and potentially influencing CLYBL. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
A polyphenol that influences metabolic pathways, could indirectly affect CLYBL activity. | ||||||
Sodium dichloroacetate | 2156-56-1 | sc-203275 sc-203275A | 10 g 50 g | $55.00 $209.00 | 6 | |
Alters mitochondrial metabolism, could have indirect effects on CLYBL function. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
A compound known to affect metabolic processes, potentially influencing CLYBL. | ||||||
α-Lipoic Acid | 1077-28-7 | sc-202032 sc-202032A sc-202032B sc-202032C sc-202032D | 5 g 10 g 250 g 500 g 1 kg | $69.00 $122.00 $212.00 $380.00 $716.00 | 3 | |
An antioxidant that affects mitochondrial function, might indirectly impact CLYBL. | ||||||
Nicotinamide riboside | 1341-23-7 | sc-507345 | 10 mg | $411.00 | ||
A precursor of NAD+ that influences mitochondrial metabolism, could affect CLYBL. | ||||||
Pyruvic acid | 127-17-3 | sc-208191 sc-208191A | 25 g 100 g | $41.00 $96.00 | ||
A key intermediate in energy metabolism, could indirectly modulate CLYBL activity. | ||||||
Citric Acid, Anhydrous | 77-92-9 | sc-211113 sc-211113A sc-211113B sc-211113C sc-211113D | 500 g 1 kg 5 kg 10 kg 25 kg | $50.00 $110.00 $145.00 $248.00 $598.00 | 1 | |
As a substrate in the tricarboxylic acid cycle, it could influence CLYBL-related pathways. | ||||||
Coenzyme Q10 | 303-98-0 | sc-205262 sc-205262A | 1 g 5 g | $71.00 $184.00 | 1 | |
Involved in the mitochondrial electron transport chain, could affect CLYBL indirectly. | ||||||